Two Bio-science Companies United to Help inside the Diagnosis of Lung Cancer
Bioview will develop in automated cancer screening system to carry out Abbott Molecular's lung cancer diagnostic test.
Abbott Molecular's current test to separate between different kinds of lung cancer, in order to provide the proper treatment, is actually carried out manually by a laboratory technician. Automating the test will save time in addition to effort, in addition to improve accuracy.
BioView has already applied its technology to various other Abbott Molecular tests for breast in addition to bladder cancer. Each time in which these tests were approved, they boosted BioView's sales by millions of dollars.
Under the completely new collaboration, the two companies will jointly conduct clinical trials of the automated lung cancer test in order to certify in which for marketing inside the US. Abbott's manual test is actually already certified by the US Food in addition to Drug Administration (FDA). The companies estimate in which This particular process will take several months.